Cilostazol
USP/1134153 - United States Pharmacopeia (USP) Reference Standard
Synonym: 6-[4-(1-Cyclohexyl-1H-
CAS Number: 73963-72-1
Empirical Formula (Hill Notation): C20H27N5O2
Molecular Weight: 369.46
MDL Number: MFCD00866780
Linear Formula: C20H27N5O2
Product Type: Chemical
| API family | cilostazol |
| application(s) | pharmaceutical (small molecule) |
| format | neat |
| grade | pharmaceutical primary standard |
| InChI | 1S/C20H27N5O2/c26-20-12-9 |
| InChI key | RRGUKTPIGVIEKM-UHFFFAOYSA |
| manufacturer/tradename | USP |
| SMILES string | O=C1CCc2cc(OCCCCc3nnnn3C4 |
| Analysis Note: | These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind. |
| Application: | Cilostazol USP Reference standard, intended for use in specified quality tests and assays as specified in the USP compendia. Also, for use with USP monograph such as Cilostazol Tablets |
| General description: | Cilostazol is a potent cyclic nucleotide phosphodiesterase inhibitor. It is mainly used as antiplatelet agent. |
| Other Notes: | Sales restrictions may apply. |
| Symbol | GHS08 |
| Signal word | Warning |
| Hazard statements | H361d |
| Precautionary statements | P201 - P202 - P280 - P308 + P313 - P405 - P501 |
| RIDADR | NONH for all modes of transport |
| WGK Germany | WGK 3 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| UNSPSC | 41116107 |

